Catalog Number 1070275-23 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Atrial Fibrillation (1729)
|
Event Date 09/01/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
|
|
Event Description
|
It was reported that the procedure was to treat a narrow mid circumflex artery and the first obtuse marginal artery that were 75% stenosed.On (b)(6) 2014, the patient presented with angina.Therefore, a 2.75 x 23 mm and a 2.5 x 15 mm xience xpedition stent were implanted in the lesions and the patient was discharged on (b)(6) 2014.In (b)(6) 2017, the patient was re-hospitalized for atrial fibrillation.Therefore, the patient received a blood transfusion and was stable.The patient was then discharged.According to the physician, the relationship between the event and the devices is unknown.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of atrial arrhythmia is listed in the xience xpedition everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Search Alerts/Recalls
|
|